A detailed history of Redmont Wealth Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Redmont Wealth Advisors LLC holds 358 shares of BMY stock, worth $20,846. This represents 0.03% of its overall portfolio holdings.

Number of Shares
358
Previous 358 -0.0%
Holding current value
$20,846
Previous $14,000 28.57%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$40.25 - $52.99 $20,125 - $26,495
-500 Reduced 58.28%
358 $14,000
Q1 2024

Apr 19, 2024

BUY
$47.98 - $54.4 $41,166 - $46,675
858 New
858 $46,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Redmont Wealth Advisors LLC Portfolio

Follow Redmont Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmont Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmont Wealth Advisors LLC with notifications on news.